106 related articles for article (PubMed ID: 18308523)
1. Velocity of radial expansion of contrast-enhancing gliomas and the effectiveness of radiotherapy in individual patients: a proof of principle.
Swanson KR; Harpold HL; Peacock DL; Rockne R; Pennington C; Kilbride L; Grant R; Wardlaw JM; Alvord EC
Clin Oncol (R Coll Radiol); 2008 May; 20(4):301-8. PubMed ID: 18308523
[TBL] [Abstract][Full Text] [Related]
2. Automatic glioma characterization from dynamic susceptibility contrast imaging: brain tumor segmentation using knowledge-based fuzzy clustering.
Emblem KE; Nedregaard B; Hald JK; Nome T; Due-Tonnessen P; Bjornerud A
J Magn Reson Imaging; 2009 Jul; 30(1):1-10. PubMed ID: 19557840
[TBL] [Abstract][Full Text] [Related]
3. Imaging after GliaSite brachytherapy: prognostic MRI indicators of disease control and recurrence.
Kleinberg L; Yoon G; Weingart JD; Parisi M; Olivi A; Detorie NA; Chan TA
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1385-91. PubMed ID: 19394153
[TBL] [Abstract][Full Text] [Related]
4. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
5. A mathematical model of the treatment and survival of patients with high-grade brain tumours.
Kirkby NF; Jefferies SJ; Jena R; Burnet NG
J Theor Biol; 2007 Mar; 245(1):112-24. PubMed ID: 17084863
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomas.
Samnick S; Romeike BF; Lehmann T; Israel I; Rübe C; Mautes A; Reiners C; Kirsch CM
J Nucl Med; 2009 Dec; 50(12):2025-32. PubMed ID: 19910430
[TBL] [Abstract][Full Text] [Related]
7. [Dynamic characterization of the growth of brain tumors based on image sequences of nuclear magnetic resonance].
Tracqui P; Leitner F; Esteve F
Bull Cancer; 1995 Dec; 82 Suppl 5():530s-535s. PubMed ID: 8680060
[TBL] [Abstract][Full Text] [Related]
8. [Proton magnetic resonance spectroscopic imaging and other types of metabolic imaging for radiotherapy planning in adult and pediatric high-grade gliomas].
Laprie A
Cancer Radiother; 2009 Oct; 13(6-7):556-61. PubMed ID: 19766525
[TBL] [Abstract][Full Text] [Related]
9. Biocomputing: numerical simulation of glioblastoma growth and comparison with conventional irradiation margins.
Bondiau PY; Konukoglu E; Clatz O; Delingette H; Frenay M; Paquis P
Phys Med; 2011 Apr; 27(2):103-8. PubMed ID: 21071253
[TBL] [Abstract][Full Text] [Related]
10. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
11. Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme.
Grabenbauer GG; Gerber KD; Ganslandt O; Richter A; Klautke G; Birkmann J; Meyer M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):164-9. PubMed ID: 19695435
[TBL] [Abstract][Full Text] [Related]
12. Intracerebral C6 glioma model in female hairless rats: assessment by using MRI and follow-up of irradiation.
Beauchesne PD; Pedeux RM; Bonmartin A; Bertrand S; Jouvet A; Kirchner AL; Revel R; Mornex F; Dore JF
Anticancer Res; 2003; 23(5A):3755-60. PubMed ID: 14666674
[TBL] [Abstract][Full Text] [Related]
13. A common sense approach to radiotherapy planning of glioblastoma multiforme situated in the temporal lobe.
Bokstein F; Kovner F; Blumenthal DT; Ram Z; Templehoff H; Kanner AA; Corn BW
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):900-4. PubMed ID: 18407432
[TBL] [Abstract][Full Text] [Related]
14. Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas.
Szeto MD; Chakraborty G; Hadley J; Rockne R; Muzi M; Alvord EC; Krohn KA; Spence AM; Swanson KR
Cancer Res; 2009 May; 69(10):4502-9. PubMed ID: 19366800
[TBL] [Abstract][Full Text] [Related]
15. Post-treatment complications of soft tissue tumours.
Shapeero LG; De Visschere PJ; Verstraete KL; Poffyn B; Forsyth R; Sys G; Uyttendaele D
Eur J Radiol; 2009 Feb; 69(2):209-21. PubMed ID: 19101106
[TBL] [Abstract][Full Text] [Related]
16. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
17. [Results of conventional radiotherapy of glioblastomas].
Russ U
Strahlentherapie; 1968 Feb; 135(2):136-42. PubMed ID: 4299466
[No Abstract] [Full Text] [Related]
18. A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle.
Swanson KR; Rostomily RC; Alvord EC
Br J Cancer; 2008 Jan; 98(1):113-9. PubMed ID: 18059395
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies for inhibiting invasion in glioblastoma.
Drappatz J; Norden AD; Wen PY
Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
[TBL] [Abstract][Full Text] [Related]
20. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
